A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer

NCT01526369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

75

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Paclitaxel
DRUG: Lapatinib

Sponsor

Cancer Trials Ireland